Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 270

    1.

    Matrix metalloproteinase-9, -10, and tissue inhibitor of matrix metalloproteinases-1 blood levels as biomarkers of severity and mortality in sepsis.

    Lorente L, Martín MM, Labarta L, Díaz C, Solé-Violán J, Blanquer J, Orbe J, Rodríguez JA, Jiménez A, Borreguero-León JM, Belmonte F, Medina JC, Llimiñana MC, Ferrer-Agüero JM, Ferreres J, Mora ML, Lubillo S, Sánchez M, Barrios Y, Sierra A, Páramo JA.

    Crit Care. 2009;13(5):R158. Epub 2009 Oct 2.

    PMID:
    19799791
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    Matrix-metalloproteinases and their inhibitors are elevated in severe sepsis: prognostic value of TIMP-1 in severe sepsis.

    Hoffmann U, Bertsch T, Dvortsak E, Liebetrau C, Lang S, Liebe V, Huhle G, Borggrefe M, Brueckmann M.

    Scand J Infect Dis. 2006;38(10):867-72.

    PMID:
    17008230
    [PubMed - indexed for MEDLINE]
    3.

    [Clinical value of serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 for the prediction and early diagnosis of coronary artery lesion in patients with Kawasaki disease].

    Peng Q, Zhou TF, Chen CH, Hua YM, Liu HM, Hong H, Zhang LY, Wu Q.

    Zhonghua Er Ke Za Zhi. 2005 Sep;43(9):676-80. Chinese.

    PMID:
    16191301
    [PubMed - indexed for MEDLINE]
    4.

    Plasma matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-2, and CD40 ligand levels in patients with stable coronary artery disease.

    Tayebjee MH, Lip GY, Tan KT, Patel JV, Hughes EA, MacFadyen RJ.

    Am J Cardiol. 2005 Aug 1;96(3):339-45.

    PMID:
    16054454
    [PubMed - indexed for MEDLINE]
    5.

    Relation of matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio in peripheral circulating CD14+ monocytes to progression of coronary artery disease.

    Brunner S, Kim JO, Methe H.

    Am J Cardiol. 2010 Feb 15;105(4):429-34. Epub 2010 Jan 5.

    PMID:
    20152234
    [PubMed - indexed for MEDLINE]
    6.

    The association of serum matrix metalloproteinases and their tissue inhibitor levels with scleroderma disease severity.

    Toubi E, Kessel A, Grushko G, Sabo E, Rozenbaum M, Rosner I.

    Clin Exp Rheumatol. 2002 Mar-Apr;20(2):221-4.

    PMID:
    12051403
    [PubMed - indexed for MEDLINE]
    7.

    Serum MMP-8, -9 and TIMP-1 in sepsis: high serum levels of MMP-8 and TIMP-1 are associated with fatal outcome in a multicentre, prospective cohort study. Hypothetical impact of tetracyclines.

    Lauhio A, Hästbacka J, Pettilä V, Tervahartiala T, Karlsson S, Varpula T, Varpula M, Ruokonen E, Sorsa T, Kolho E.

    Pharmacol Res. 2011 Dec;64(6):590-4. Epub 2011 Jul 1.

    PMID:
    21742038
    [PubMed - indexed for MEDLINE]
    8.
    9.

    Matrix metalloproteinase-1 and cytokines in patients with acute pancreatitis.

    Nakae H, Endo S, Inoue Y, Fujino Y, Wakabayashi G, Inada K, Sato S.

    Pancreas. 2003 Mar;26(2):134-8.

    PMID:
    12604910
    [PubMed - indexed for MEDLINE]
    10.

    Circulating matrix metalloproteinases 1, 2, 9 and their inhibitors TIMP-1 and TIMP-2 as serum markers of liver fibrosis in patients with chronic hepatitis C: comparison with PIIINP and hyaluronic acid.

    Leroy V, Monier F, Bottari S, Trocme C, Sturm N, Hilleret MN, Morel F, Zarski JP.

    Am J Gastroenterol. 2004 Feb;99(2):271-9.

    PMID:
    15046217
    [PubMed - indexed for MEDLINE]
    11.

    [Serum and urinary concentration of selected metalloproteinases and their tissue inhibitors in children with vesicoureteral reflux].

    Taranta-Janusz K, Zoch-Zwierz W, Wasilewska A, Tenderenda E, Korzeniecka-Kozerska A.

    Pol Merkur Lekarski. 2010 Aug;29(170):88-92. Polish.

    PMID:
    20842819
    [PubMed - indexed for MEDLINE]
    12.

    Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.

    Keyszer G, Lambiri I, Nagel R, Keysser C, Keysser M, Gromnica-Ihle E, Franz J, Burmester GR, Jung K.

    J Rheumatol. 1999 Feb;26(2):251-8.

    PMID:
    9972954
    [PubMed - indexed for MEDLINE]
    13.

    Matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in patients with relapsing-remitting multiple sclerosis treated with interferon beta.

    Boz C, Ozmenoglu M, Velioglu S, Kilinc K, Orem A, Alioglu Z, Altunayoglu V.

    Clin Neurol Neurosurg. 2006 Feb;108(2):124-8.

    PMID:
    16412833
    [PubMed - indexed for MEDLINE]
    14.

    Plasma levels of matrix metalloproteinase-9 in chronic urticaria patients correlate with disease severity and C-reactive protein but not with circulating histamine-releasing factors.

    Tedeschi A, Asero R, Lorini M, Marzano AV, Cugno M.

    Clin Exp Allergy. 2010 Jun;40(6):875-81. Epub 2010 Mar 4.

    PMID:
    20214668
    [PubMed - indexed for MEDLINE]
    15.

    Matrix metalloproteinases and inflammatory markers in coronary artery ectasia: their relationship to severity of coronary artery ectasia.

    Dogan A, Tuzun N, Turker Y, Akcay S, Kaya S, Ozaydin M.

    Coron Artery Dis. 2008 Dec;19(8):559-63.

    PMID:
    19005290
    [PubMed - indexed for MEDLINE]
    16.

    Serum matrix metalloproteinases MMP-2 and MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in diabetic nephropathy.

    Rysz J, Banach M, Stolarek RA, Pasnik J, Cialkowska-Rysz A, Koktysz R, Piechota M, Baj Z.

    J Nephrol. 2007 Jul-Aug;20(4):444-52.

    PMID:
    17879211
    [PubMed - indexed for MEDLINE]
    17.

    Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer.

    Oberg A, Höyhtyä M, Tavelin B, Stenling R, Lindmark G.

    Anticancer Res. 2000 Mar-Apr;20(2B):1085-91.

    PMID:
    10810401
    [PubMed - indexed for MEDLINE]
    18.

    [Plasma matrix metalloproteinases MMP-2 and MMP-9 and tissue inhibitors TIMP-1 and TIMP-2 in children treated for acute lymphoblastic leukemia].

    Krawczuk-Rybak M, Kuźmicz M, Mroczko B, Szmitkowski M.

    Pol Merkur Lekarski. 2010 Jul;29(169):14-8. Polish.

    PMID:
    20712241
    [PubMed - indexed for MEDLINE]
    19.

    Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.

    Niebroj-Dobosz I, Janik P, Sokołowska B, Kwiecinski H.

    Eur J Neurol. 2010 Feb;17(2):226-31. Epub 2009 Oct 1.

    PMID:
    19796283
    [PubMed - indexed for MEDLINE]
    20.

    Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer--TIMP-1 as a prognostic marker.

    Ylisirniö S, Höyhtyä M, Turpeenniemi-Hujanen T.

    Anticancer Res. 2000 Mar-Apr;20(2B):1311-6.

    PMID:
    10810441
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk